TALS
Talaris Therapeutics Inc
Price:  
2.72 
USD
Volume:  
305,272.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

TALS WACC - Weighted Average Cost of Capital

The WACC of Talaris Therapeutics Inc (TALS) is 6.8%.

The Cost of Equity of Talaris Therapeutics Inc (TALS) is 9.90%.
The Cost of Debt of Talaris Therapeutics Inc (TALS) is 5.00%.

Range Selected
Cost of equity 8.80% - 11.00% 9.90%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 6.2% - 7.3% 6.8%
WACC

TALS WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 0.92 0.97
Additional risk adjustments 0.0% 0.5%
Cost of equity 8.80% 11.00%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 6.2% 7.3%
Selected WACC 6.8%